Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

For patients who may benefit from such scans, it's unclear whether including the spine as well as the sacroiliac joint ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, making it more applicable in clinical settings. The algorithm outperformed ...

Zenas Biopharma’s autoimmune drug candidate has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study. The midstage MoonStone study saw 116 ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Matthew Brier, MD, ...

A 60-year-old man with a significant smoking history and breast cancer presented to the emergency department with severe back and left lower extremity pain. Clinical evaluation revealed metastatic ...

Fossilized bones in Brazil reveal that deadly infections plagued sauropods 80 million years ago. Researchers uncovered unhealed lesions consistent with osteomyelitis, pointing to pathogens spread ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...